MedPath

Investigating the effect of Byolic CC product consumption along with standard treatment in patients with colon cancer

Phase 2
Recruiting
Conditions
colon cancer.
Malignant neoplasm of colon
Registration Number
IRCT20240304061158N3
Lead Sponsor
Behpad Teb Iranian
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria

Diagnosis of colon cancer in colonoscopy with histopathological examination

Exclusion Criteria

Necessity of surgery or emergency operation or radiotherapy
Active infection
Systemic immune disorders
history of inflammatory bowel diseases
pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Karnofsky performance scale index. Timepoint: The Karnofsky index will be calculated on day zero at the beginning of the study and day 60 at the end of the study. Method of measurement: The Karnofsky index is measured using physical examination checklist.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath